Back
Fulcrum Therapeutics Vs. Entrada Therapeutics Industry Stock Comparison
Sell
19
FULC
Fulcrum Therapeutics
Last Price:
3.81
Seasonality Move:
37.25%
Buy
55
TRDA
Entrada Therapeutics
Last Price:
17.08
Seasonality Move:
6.92%
Sell
19
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.67. The Score for FULC is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $16.44. The Score for TRDA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing selling pressure, which indicates risk of future bearish movement.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $16.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight buying pressure.
FULC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.1 | Sell |
Relative Strength Index (14 RSI): | 33.74 | Sell |
Chaikin Money Flow: | -476921 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.88 - 7.74) | Sell |
Bollinger Bands (100): | (5.41 - 9.21) | Sell |
TRDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 57.88 | Buy |
Chaikin Money Flow: | 37888 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.46 - 16.34) | Buy |
Bollinger Bands (100): | (14.55 - 16.63) | Buy |
FULC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.64 | Buy |
20-day SMA: | 4.52 | Sell |
50-day SMA: | 7.16 | Sell |
200-day SMA: | 7.82 | Sell |
8-day EMA: | 3.74 | Sell |
20-day EMA: | 4.61 | Sell |
50-day EMA: | 6.16 | Sell |
200-day EMA: | 7.08 | Sell |
TRDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.93 | Buy |
20-day SMA: | 15.16 | Buy |
50-day SMA: | 15.65 | Buy |
200-day SMA: | 14.78 | Buy |
8-day EMA: | 15.92 | Buy |
20-day EMA: | 15.59 | Buy |
50-day EMA: | 15.56 | Buy |
200-day EMA: | 15.05 | Buy |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.79 per share.
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
Fulcrum Therapeutics Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Entrada Therapeutics Technical Analysis
Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |